ZINZINO AB (PUBL): Announcement from the annual general meeting

Report this content

Zinzino AB (publ.) held an annual general meeting today, May 27, 2024, where it was mainly decided:

  • to determine profit and loss accounts and balance sheets for the parent company and the group,
  • to distribute SEK 3.00 per share for the financial year 2023 and transfer the remaining part of the balanced profit in a new account,
  • to grant the board and CEO discharge from liability,
  • to elect Hans Jacobsson as chairman of the board and Staffan Hillberg, Pierre Mårtensson, Ingela Nordenhav and Anna Frick as other board members,
  • that a total of SEK 1,180,000 in board fees shall be paid, of which SEK 320,000 to the chairman, SEK 180,000 to each of the other board members, SEK 60,000 to the chairman of the audit committee and SEK 30,000 to a member of the audit committee and SEK 25,000 to the chairman of the remuneration committee and 20,000 to a member of the remuneration committee.
  • to choose BDO Göteborg AB as audit firm and Katarina Eklund as auditor in charge,
  • to establish principles for the nomination committee in accordance with the nomination committee's proposal before the 2025 annual general meeting,
  • to issue 110,270 new Zinzino B shares with payment by offsetting the claim to Enhanzz AG,
  • to give the board the authority to decide on rights issues,
  • to give the board the authority to decide on targeted issues of a maximum total of 3,000,000 B shares,
  • to approve the remuneration report presented by the board for 2023,
  • The complete decisions of the Annual General Meeting are available at the company's head office in Gothenburg.
  • It was noted that the required majority of at least 9/10 of both the votes cast and the shares represented at the general meeting was achieved.

Gothenburg on 27 May 2024

The Board of Zinzino

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
marketing@zinzino.com

Certified Adviser: Carnegie Investment Bank AB (publ)

Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia.